What’s New


Jan 8, 2024

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. Th…


Nov 8, 2023

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial in…


Sep 13, 2022

Discovery Accelerated: Clinical Trials in Pediatric IBD


Mar 22, 2022

Discovery Accelerated: Drug Development in NASH


Nov 16, 2021

Discovery Accelerated: Real World Evidence in Drug Development in IBD


Jun 24, 2021

Discovery Accelerated: Drug Development and Outcome Measures in Eosinophilic Esophagitis (EGID)


Apr 26, 2021

Discovery Accelerated: Implementation of Histopathology in Gastrointestinal Clinical Trials


Mar 29, 2021

Discovery Accelerated: Targeting Intestinal Fibrosis in Inflammatory Bowel Disease